| Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer P Sharma, T Shimura, JK Banwait, A Goel Carcinogenesis 41 (10), 1385-1394, 2020 | 58 | 2020 |
| miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42 P Sharma, N Saini, R Sharma Oncology reports 37 (5), 3116-3127, 2017 | 51 | 2017 |
| Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer T Shimura, P Sharma, GG Sharma, JK Banwait, A Goel Scientific Reports 11 (1), 7548, 2021 | 39 | 2021 |
| Decreased levels of circulating and tissue miR-107 in human esophageal cancer P Sharma, A Saraya, P Gupta, R Sharma Biomarkers 18 (4), 322-330, 2013 | 39 | 2013 |
| miRNA–mRNA crosstalk in esophageal cancer: From diagnosis to therapy P Sharma, R Sharma Critical Reviews in Oncology/Hematology 96 (3), 449-462, 2015 | 28 | 2015 |
| Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer P Sharma, A Saraya, R Sharma Indian Journal of Medical Research 143 (Suppl 1), S91-S103, 2016 | 16 | 2016 |
| Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL S Piya, Y Yang, S Bhattacharya, P Sharma, H Ma, H Mu, H He, V Ruvolo, ... Leukemia 36 (5), 1261-1273, 2022 | 14 | 2022 |
| Serum‐based six‐miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA–mRNA target pairs by integrated … P Sharma, A Saraya, R Sharma Asia‐Pacific Journal of Clinical Oncology 14 (5), e289-e301, 2018 | 12 | 2018 |
| miR-144 functions as an oncomiR in KYSE-410 human esophageal carcinoma cell line in vitro and targets PURA P Sharma, R Sharma Neoplasma 65 (4), 542-551, 2018 | 5 | 2018 |
| Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia S Bhattacharya, S Piya, H Ma, P Sharma, Q Zhang, N Baran, VR Ruvolo, ... Molecular Cancer Research 21 (6), 548-563, 2023 | 4 | 2023 |
| Abstract B43: Evaluation of a miRNA-mRNA panel for esophageal cancer detection P Sharma, A Saraya, R Sharma Cancer research 76 (6_Supplement), B43-B43, 2016 | 2 | 2016 |
| Tolinapant (ASTX660) enhances the anti-leukemic activity of Venetoclax and Dexamethasone in T cell acute lymphoblastic leukemia (T-ALL) P Sharma, S Piya, H Ma, N Baran, M Muftuoglu, M Basyal, V Ruvolo, ... Cancer Research 82 (12_Supplement), 5337-5337, 2022 | 1 | 2022 |
| ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Inhibiting Drp1 Dependent Mitochondrial Fission P Sharma, LB Ostermann, S Piya, B Ke, N Baran, A Tyagi, M Muftuoglu, ... Blood 142 (Supplement 1), 412-412, 2023 | | 2023 |
| Mitophagy As a Novel Cell-Protective Mechanism Against Mitochondrial Ferroptosis in Acute Myeloid Leukemia H Akiyama, M Tcheng, P Sharma, R Zhao, LB Ostermann, S Yazdani, ... Blood 142 (Supplement 1), 2804-2804, 2023 | | 2023 |
| Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia P Sharma, G Borthakur Cancer Drug Resistance 6 (3), 567, 2023 | | 2023 |
| Aberrant Expression of FGFRL1 in Esophageal Cancer and Its Regulation by miR-107 P Sharma, V Kaushik, A Saraya, R Sharma Asian Pacific Journal of Cancer Prevention: APJCP 24 (4), 1331, 2023 | | 2023 |
| ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Altering Drp1-Dependent Mitochondrial Fission and Metabolism P Sharma, S Piya, N Baran, A Zal, CJ Hindley, KH Dao, M Sims, T Zal, ... Blood 140 (Supplement 1), 8789-8790, 2022 | | 2022 |
| Inhibition of De Novo Pyrimidine Synthesis Depletes Acute Myleogenous Leukemia Stem Cells (LSCs) Burden and Triggers Apoptosis and Differentiation Associated with Oxidative Stress S Piya, H Ma, P Sharma, K Kojima, V Ruvolo, M Basyal, N Baran, ... Blood 138 (Supplement 1), 2249-2249, 2021 | | 2021 |
